Bioceres Crop Solutions Past Earnings Performance
Past criteria checks 2/6
Bioceres Crop Solutions has been growing earnings at an average annual rate of 47.5%, while the Chemicals industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 24.2% per year. Bioceres Crop Solutions's return on equity is 1.1%, and it has net margins of 0.6%.
Key information
47.5%
Earnings growth rate
51.2%
EPS growth rate
Chemicals Industry Growth | 12.9% |
Revenue growth rate | 24.2% |
Return on equity | 1.1% |
Net Margin | 0.6% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting
Nov 13Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper
Sep 28Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices
Sep 17These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively
Aug 03Bioceres Needs To Add Clarity Around Borrowings
Mar 23Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt
Feb 03Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
Oct 04Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear
Jun 21Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load
May 09Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings
Sep 06Bioceres Crop Solutions jumps 15% after investor pitch
Aug 23We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt
Apr 10Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness
Mar 31Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?
Mar 17Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?
Nov 13Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Jul 08Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)
Jun 16What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?
May 26Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products
May 10Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
May 05Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Apr 05Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?
Mar 10Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year
Feb 12Revenue & Expenses Breakdown
How Bioceres Crop Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 441 | 2 | 103 | 17 |
30 Jun 24 | 465 | 3 | 107 | 17 |
31 Mar 24 | 446 | 3 | 106 | 16 |
31 Dec 23 | 455 | 22 | 104 | 16 |
30 Sep 23 | 409 | 14 | 102 | 16 |
30 Jun 23 | 419 | 19 | 99 | 15 |
31 Mar 23 | 416 | 15 | 95 | 13 |
31 Dec 22 | 391 | -19 | 88 | 11 |
30 Sep 22 | 389 | -8 | 78 | 9 |
30 Jun 22 | 328 | -7 | 65 | 7 |
31 Mar 22 | 308 | -2 | 58 | 7 |
31 Dec 21 | 275 | 4 | 52 | 6 |
30 Sep 21 | 231 | 1 | 46 | 6 |
30 Jun 21 | 207 | -7 | 45 | 6 |
31 Mar 21 | 174 | -5 | 37 | 4 |
31 Dec 20 | 164 | -7 | 35 | 4 |
30 Sep 20 | 178 | 3 | 34 | 4 |
30 Jun 20 | 172 | 3 | 33 | 4 |
31 Mar 20 | 174 | 0 | 36 | 5 |
31 Dec 19 | 167 | -18 | 36 | 5 |
30 Sep 19 | 167 | -23 | 36 | 4 |
30 Jun 19 | 160 | -18 | 34 | 4 |
31 Mar 19 | 142 | -26 | 29 | 3 |
31 Dec 18 | 145 | -8 | 28 | 3 |
30 Sep 18 | 129 | -13 | 29 | 4 |
30 Jun 18 | 133 | -11 | 31 | 4 |
30 Jun 17 | 94 | -12 | 27 | 4 |
31 Dec 16 | 41 | -6 | 8 | 1 |
31 Dec 15 | 5 | -1 | 1 | 0 |
Quality Earnings: BIOX has high quality earnings.
Growing Profit Margin: BIOX's current net profit margins (0.6%) are lower than last year (3.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOX has become profitable over the past 5 years, growing earnings by 47.5% per year.
Accelerating Growth: BIOX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BIOX had negative earnings growth (-82.2%) over the past year, making it difficult to compare to the Chemicals industry average (-0.5%).
Return on Equity
High ROE: BIOX's Return on Equity (1.1%) is considered low.